62
Participants
Start Date
February 4, 2022
Primary Completion Date
September 4, 2027
Study Completion Date
February 4, 2030
Capecitabine
Capecitabine will given at 1250mg/m², 2 times a day with an interval of about 12 hours between two intakes, 2 weeks on, 1 week off, for 4 pre-surgery cycles.
Selective Internal Radiotherapy (SIRT)
During the first week of cycle 2 of capecitabine, patients will receive SIRT using Yttrium-90 glass microspheres. Treatment with Yttrium-90 glass microspheres requires two steps, one or two weeks apart. Both stages are performed under local anesthesia after a short hospitalization : the treatment simulation and therapeutic angiography.
Surgery
Surgery will be performed according to local practice.
RECRUITING
Groupe SUD-Haut-Lévêque - Centre Hospitalier Universitaire de Bordeaux, Pessac
ACTIVE_NOT_RECRUITING
Centre Hospitalier Universitaire de Montpellier, Montpellier
RECRUITING
Centre de Lutte contre le Cancer Eugène Marquis, Rennes
ACTIVE_NOT_RECRUITING
Centre Hospitalier Universitaire de Poitiers, Poitiers
RECRUITING
Hôpital Beaujon, Clichy
ACTIVE_NOT_RECRUITING
Hôpital Henri - Mondor, Créteil
RECRUITING
Gustave Roussy, Villejuif
Center Eugene Marquis
OTHER